Parkinson's disease (PD) is a neurodegenerative disorder that produces both motor and non-
motor complications, degrading the quality of life of PD patients. Over the past two decades …

Since its first introduction, levodopa has become the cornerstone for the treatment of
Parkinson's disease and remains the leading therapeutic choice for motor control therapy so …

Background: Dyskinesias and freezing of gait are episodic disorders in Parkinson's disease,
characterized by a fluctuating and unpredictable nature. This cross-sectional study aims to …

Background: Studies aiming to objectively quantify movement disorders during upper limb
tasks using wearable sensors have recently increased, but there is a wide variety in …

Parkinson's Disease (PD) patients frequently transition between the 'ON'state, where
medication is effective, and the 'OFF'state, affecting their quality of life. Monitoring these …

Accurate and reliable measurement of the severity of dystonia is essential for the indication,
evaluation, monitoring and fine-tuning of treatments. Assessment of dystonia in children and …

Motor coordination is an important driver of development and improved coordination
assessments could facilitate better screening, diagnosis, and intervention for children at risk …

The Unified Parkinson's Disease Rating Scale (UPDRS) is used to recognize patients with
Parkinson's disease (PD) and rate its severity. The rating is crucial for disease progression …

Hyperkinesias are heterogeneous involuntary movements that significantly differ in terms of
clinical and semeiological manifestations, including rhythm, regularity, speed, duration, and …

Parkinson's disease affects millions worldwide with a large rise in expected burden over the
coming decades. More easily accessible tools and techniques to diagnose and monitor …